Trials / Conditions / HER-2-positive Advanced Breast Cancer
HER-2-positive Advanced Breast Cancer
3 registered clinical trials studyying HER-2-positive Advanced Breast Cancer — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Phase Ib/II Study of Zanidatamab Plus Tucatinib and Chemotherapy in HER2-Positive Advanced Breast Cancer NCT07494448 | MedSIR | Phase 1 / Phase 2 |
| Recruiting | A Real-World Study of Pyrrolitinib Maleate Tablets for HER-2-Positive Early or Locally Advanced Breast Cancer NCT06470347 | Zunyi Medical College | Phase 1 / Phase 2 |
| Unknown | Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection NCT04164615 | Genor Biopharma Co., Ltd. | Phase 3 |